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Abstract Sinonasal inverted papilloma is a rare benign epithelial tumor. Its three main clinical 
characteristics are the tendency of recurrence, the destructive ability of nearby structures and 
malignant transformation. The primary manifestations of this tumor include nasal obstruction, 
headaches, runny nose, hemorrhage and impaired sense of smell. The diagnosis is based on the 
clinical and endoscopic examination completed by CT or MRI scans and biopsy of the lesion. 
Allergies, chronic inflammation, nicotinism and viral infections such as HPV infection are 
considered possible causes of pathogenesis and potential risk factors for relapse and malignancy. 
The treatment for this condition is the complete removal of the tumor with disease-free 
margins. Postoperative follow-up is essential for the early detection of recurrence or malignant 
transformation. One of the most basic and important steps in managing these patients is to 
acknowledge the presence of the mentioned risk factors and avoid exposure. Due to the high risk 
of relapse, the follow-up must be aggressive and thorough and always include the endoscopic 
examination. 
In our article, we wish to highlight the importance of the proper surgical intervention, but also 
the difference in the overall outcome of the patient ensured by the correct management of the risk 
factors, allowing us to prevent recurrence and malignant transformation. 
 
Keywords  inverted papilloma, recurrence, malignant transformation, risk factors 
Highlights  The tendency for recurrence, the local destructive ability and the risk of malignant 
transformation are the main problems posed by sinonasal inverted papillomata. 
 The complete removal of the tumor and an aggressive follow-up are necessary for a good 
outcome for the patient.  
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Introduction 
The sinonasal inverted papilloma is a rare benign 
epithelial tumor that derives from the Schneiderian 
membrane. The Schneiderian membrane is a ciliated 
columnar epithelium that originates in the ectodermis and 
forms a boundary between the sinus and nasal mucosa (1). 
This pathology is classified into three types: oncocytic, 
fungiform and inverted papilloma, which is the most 
common type. The inverted papilloma is more frequent in 
men than in women with the onset between the 4th and the 
7th decade of life (1). 
This tumor is usually unilateral, with its origin on the 
lateral wall of the nasal cavity in the middle meatal area. 
The growth of the inverted papilloma is inward in 
fingerlike projections. They are locally aggressive and are 
characterised by rapid growth with the destruction of 
nearby areas and bone erosion that can dramatically 
change the anatomical landmarks of the nasal cavity and 
sinuses. Other characteristics of the inverted papilloma 
are the invasion of the adjacent regions of the facial 
skeleton and anterior skull base, its tendency to recur and 
the risk of malignant transformation (2). 
The pathogenesis of inverted papilloma is unclear. 
Allergies, chronic inflammation, nicotinism, viral 
infections such as HPV infection, diabetes, hypertension 
are considered possible causes (3, 4).  
The primary manifestations of this tumor include nasal 
obstruction, headaches, runny nose, bleeding, impaired 
sense of smell. These symptoms can be accompanied by 
impaired vision and facial pain (5). 
The majority of inverted papillomata are discovered 
during a physical ENT examination. For a better 
visualisation of the tumor, nasal endoscopy is performed. 
Their macroscopic appearance is a red-grey polypoid 
tumor, with an uneven surface that may bleed upon 
touching. Furthermore, the radiologic examination is 
needed to evaluate the extent of the tumor and the lesions 
of nearby structures. Because of its bone erosion 
characteristic, some surgeons consider CT scans the 
radiologic evaluation of choice, but CT scanning does not 
allow a proper differentiation between soft tissue and 
secretions. To avoid a wrong interpretation of the extent 
of the tumor, sometimes a complementary MRI is needed 
(6, 7). 
The most frequent method used to evaluate the clinical 
preoperative severity is the Krouse classification, 
considering tumor location and malignancy: 
T1: tumor restricted to the nasal cavity only 
T2: tumor limited to ethmoid cells and/or the medial wall 
of the maxillary sinus 
T3: tumor extending to the lateral, inferior, superior, 
anterior, or posterior wall of the maxillary sinus or 
penetrating the sphenoid or frontal sinus 
T4: tumor extending beyond the sinonasal boundaries or 
any malignant tumor (8). 
Discussions 
Literature data 
In order to assess the current practice regarding 
patients with inverted papillomata, we researched the 
available data and studies in the Medline database. For 
this purpose, a number of 5 studies and 23 articles on the 
topic and related data were reviewed, searching for a 
significant combination of terms that included: inverted 
papilloma recurrence, malignant transformation and risk 
factors. We only took into account the data relevant for 
the subject discussed. We researched both the method of 
choice for surgery according to the extension of the tumor 
and the protocol for the follow-up program. 
In patients with inverted papilloma, the surgeon aims 
to remove an entire tumor. The surgical strategies varied 
over the years (9). 
For a long time, lateral rhinotomy with medial 
maxillectomy and ethmoidectomy had been considered 
the treatment of choice, but with the development of 
endoscopy in the field of ENT, new and less invasive 
procedures have appeared (9). 
Nowadays, endoscopic sinus surgery with the removal 
of the entire tumor represents “the gold standard” 
treatment for inverted papillomata. The advantages of 
endoscopic surgery are no external scars, good 
intraoperative visualisation of the lesion and adjacent 
structures, shorter healing periods and hospitalisation time 
(10). 
However, in some cases, both endoscopic and external 
approaches are required to resect the entire lesion. The 
approach is chosen following the Krouse classification. 
According to this staging, patients with T1 and T2 tumors 
can undergo successful endoscopic surgery, and patients 
with stages T3 and T4 need a combined approach (11). 
The elective investigations for inverted papillomata 
are computed tomography (CT) and magnetic resonance 
imaging (MRI). CT images are preferable because of the 
bony structure visualization, allowing to locate the 
papilloma attachment site, represented by a focal 
hyperostosis (12). 
Sinonasal inverted papilloma 
 74 
It was noted that endoscopic procedures performed by 
experienced surgeons present a lower risk of tumor 
recurrence than the external approach (13). 
The surgical strategy is to reveal the insertion of the 
tumor and then to remove it entirely, if possible. After the 
removal of the tumor, the drilling of the insertion area is 
required to minimize the risk of recurrence. If the tumor 
extends to the orbital fossa or cerebral cranium, it is safer 
to segment the tumor and remove it piecemeally. At the 
end of surgery, the remaining cavity must be large enough 
to ensure optimal endoscopic follow-up procedures. 
Complications such as hemorrhage from the 
sphenopalatine artery, internal maxillary artery or anterior 
ethmoidal artery, orbital complications or CSF leaks may 
occur due to the nearby important anatomical structures. 
Postoperative follow-up is very important to detect 
relapse or malignant transformation in the early stages. In 
our clinic, the follow-up consists in an endoscopic 
examination of the patient every three months in the first 
two years and every six months in the next two years. If 
recurrence is suspected, a radiological evaluation is 
performed. 
Results 
The endoscopic approach is an overall method with 
excellent results, thus easier to accept by the patient. The 
advancements in the technological area have made the 
resection of large tumors in safe conditions possible. 
Also, the absence of any scars makes patients more prone 
to accept the intervention and present a higher adherence 
to the management protocol. 
However, we must not rely on endoscopy alone. At 
any point of the intervention, the surgeon may be forced 
to switch to an open approach, or in cases of largely 
extensive tumors, this may be the method of choice from 
the beginning. That is why any surgeon approaching this 
pathology must be thoroughly prepared to perform an 
open approach as well. 
Another subject that must be underlined is the 
advantage offered by a combined approach, with a lateral 
rhinotomy completed with the endoscopic control of the 
underlying areas. At any point, the magnified image 
offered by endoscopy will increase the degree of safety 
and will help expose areas that may be difficult to be only 
visually assessed, regardless of one’s experience. This is 
the preferable method for large extensive tumors, 
especially if located in the vicinity of vital structures. This 
may be the case due to the tendency of extension of 
inverted papillomata. This applies more often to cases 
with malignant degeneration, with late presentation to the 
doctor and delayed diagnosis. 
The method of choice in treating patients with this 
pathology remains surgery. The tumor must be 
completely resected in order to avoid recurrence. We 
believe that the endoscopic approach can be considered 
the method of choice nowadays. It offers the possibility to 
completely resect the tumor in safe conditions, with 
minimal trauma for the patient and a faster recovery 
period. Also, the limited scarring and fibrosis increase the 
adherence to treatment and facilitate the follow-up. The 
process of regular appointments and endoscopic 
examinations has proven to be equally important to avoid 
postoperative complications and if any recurrence occurs, 
to provide a fast re-intervention. 
Interpretations 
Incomplete tumor resection or positive surgical 
margins represent the leading cause of recurrence of the 
inverted papilloma. Therefore, a proper selection of the 
surgical approach based on the preoperative nasal 
endoscopy and radiological examination is needed. 
Pathological mucosal fragments left within the 
anfractuosities of the bone can also be a cause of 
recurrence; therefore, the resection of the bone should be 
considered after the excision of the tumor.  
For a good outcome, the tumor needs to be resected 
along with the periosteum, paying extra attention to the 
origin site of the tumor shown on CT scans. A five-
millimeter resection margin is recommended to obtain 
free surgical margins. Moreover, an intraoperative 
histopathological investigation can be done to prove 
negative resection margins. Even if surgery was well 
performed and free margins were insured, inverted 
papilloma recurrence may occur in distant locations from 
the primary site. The explanation for this type of 
recurrence is the multicenter origin of the inverted 
papilloma theory. 
According to the relation between the stage of the 
tumor and the recurrence rate, it was noted that patients 
with T3-T4 stages (Krouse classification) present a higher 
risk of recurrence than patients with T1-T2 stages. 
However, the difference between the recurrence based on 
the different stages of the tumor is not significant enough 
to formulate a hypothesis (8, 11) (Table 1). 
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Table 1. Risk factors for the recurrence of inverted 
papilloma 
Factors Publications 
Age of patients: young > old Jardine et al., 2000 (14) 
Sex ratio: female > men Suh et al., 1977 (15) 
Smoking Roh et al., 2016 (16) 
Histopathology  
Hyperkeratosis + squamous 
hyperplasia 
Katori et al., 2006 (17) 
High mitotic index  
Lack of inflamed polyps  
Elevated number of 
aneuploid cells 
Liu, 1990 (18) 
The approach of the inverted papilloma can also be 
considered a risk factor for recurrence. Several studies 
have revealed better results with fewer recurrence rates 
for the endoscopic approach than the external one (19, 
20). 
The results of the studies regarding the relation 
between HPV and the onset of inverted papilloma are 
controversial. It is believed that the E6 and E7 viral 
oncoproteins play an important role in the genesis of the 
tumor and especially patients diagnosed with HPV-18 
present a high risk of malignant transformation of the 
inverted papilloma (21, 22). 
Another risk factor for recurrence and malignant 
transformation is smoking. It causes chronic inflammation 
of the sinonasal mucosa which leads to a higher relapse 
chance, but no conclusions were made regarding its 
relationship with malignant transformation (23, 24). 
Several studies regarding the correlation between the 
recurrence risk and the location of the inverted papilloma 
were made. The results of the studies revealed that the 
inverted papilloma originating in the nasal cavity had 
reduced the recurrence risk compared with the ones that 
originate in the sinuses, especially in the frontal sinus. 
The reasons can be earlier diagnosis and a more 
accessible surgical approach (25). 
Patients with systemic disease pose a greater 
therapeutic challenge. Out of all the comorbidities, 
coagulopathies are some of the most dangerous. These 
problems relate to both the general anesthesia that is 
necessary and the intervention itself, which can result in 
significant hemorrhages. Patients who associate other 
severe conditions, especially neurological, cardiologic or 
oncological, will associate a higher risk during the 
intervention and in the immediate period (26). 
Studies show that 9% of inverted papillomata suffer 
malignant transformation, the most common tumor being 
squamous cell carcinoma (27). The malignant tumors 
usually develop from the primary mass of the inverted 
papilloma, but they can also appear after the surgical 
treatment. The prognosis for these tumors is poor, with a 
survival rate of 5 to 10 years in 39.6% of cases. An even 
lower survival rate is noted when the malignant tumor is 
diagnosed in an advanced stage with low differentiation. 
MRI is considered a very useful method for the early 
detection of malignant transformation of inverted 
papilloma. Radiotherapy should be considered if surgery 
is contraindicated or it should be done postoperatively if 
the inverted papilloma is associated with squamous cell 
carcinoma (23). 
SCCA is the squamous cell carcinoma antigen 
released into blood circulation by the squamous cells. It 
became a nonspecific marker used in monitoring head and 
neck, ovarian, lung or hepatic carcinomata (24). Studies 
revealed increased levels of SCCA in patients with 
inverted papilloma even before a tumor can be observed 
macroscopically. Two subtypes of this protein were 
studied, SCCA1 and SCCA2. Further research is needed to 
establish if they might be useful in detecting squamous cell 
carcinoma in patients with inverted papilloma (28, 29). 
Conclusions 
Sinonasal inverted papilloma is a rare tumor that 
almost always develops unilaterally. Its three main 
clinical characteristics are the tendency of recurrence, the 
destructive ability of nearby structures and malignant 
transformation. The purpose of the surgical treatment is 
complete resection of the tumor with negative margins 
and drilling or removing the abnormal underlying bone. 
Regarding the surgical approach, the endoscopic 
treatment provides better results than the external 
approach. Postoperative follow-up is essential in the early 
detection of recurrence or malignant transformation. 
Usually, the follow-up consists of systematic flexible 
endoscopies and clinical examination. In case of doubt 
regarding its recurrence, MRI is performed. The MRI 
could be completed with biopsies for a positive diagnosis. 
Although literature describes possible risk factors for the 
recurrence and malignant transformation of the inverted 
papilloma, further research is needed to obtain accurate 
results. 
We wish to highlight the importance of a correct and 
complete management protocol, which must always 
include a thorough preoperative evaluation, a correct 
surgical intervention with the complete removal of the 
tumor and an aggressive follow-up program. The primary 
purpose of the intervention is to achieve a disease-free 
Sinonasal inverted papilloma 
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status. If this may be accomplished using an endoscopic 
approach alone, this situation is preferable. However, if 
this is impossible, an open or combined approach must 
always be performed. The main reason for recurrence is 
considered to be the incomplete removal, but we still 
consider that further attention must be paid to the 
evaluation and management of risk factors. 
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